XTNT Insider Trading Activity and SEC Form 4 Filings
XTNT insider trading summary
No open-market insider purchases or sales of Xtant Medical Holdings, Inc. (XTNT) have been reported on SEC Form 4 in the past 12 months.
Latest XTNT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 10, 2025 | Orbimed Advisors LLC | 10% Owner | Sell | $7.2M (17,109,618 @ $0.42) |
| Apr 10, 2025 | Orbimed ROF II LLC | 10% Owner | Sell | $7.2M (17,109,618 @ $0.42) |
| Apr 10, 2025 | Orbimed Advisors LLC | 10% Owner | Sell | $23.5M (56,004,974 @ $0.42) |
| Apr 10, 2025 | Orbimed ROF II LLC | 10% Owner | Sell | $23.5M (56,004,974 @ $0.42) |
| Nov 17, 2023 | Kevin D Brandt | Chief Commercial Officer | Buy | $50K (41,670 @ $1.20) |
| Jan 18, 2023 | Scott C Neils | Chief Financial Officer | Sell | $5K (8,673 @ $0.61) |
| Oct 19, 2022 | Sean E Browne | President and CEO | Sell | $32K (51,100 @ $0.62) |
| Oct 18, 2022 | Sean E Browne | President and CEO | Sell | $54K (80,000 @ $0.68) |
| Oct 7, 2022 | Stavros G. Vizirgianakis | Director | Buy | $1.1M (2,264,861 @ $0.48) |
| Aug 17, 2022 | Kevin D Brandt | Chief Commercial Officer | Sell | $2K (4,300 @ $0.48) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.